Leading up to the recent German elections, the topic of healthcare took center stage for the aging German population. With nearly 90% of the population participating in Statutory Health Insurance (SHI), increased financial pressures have widened the gap between SHI coverage and anticipated expenditures.
During this EPP Studio Live Webinar, Douglas Foerster, Senior Vice President of Pricing & Market Access for EVERSANA, and Mathias Flume, Head of Drug Development for KVWL, discuss how various political parties are responding to these challenges and the potential impact on market access and pricing in Germany.
Douglas leads EVERSANA’s pricing and market access team to strategically drive new drugs to the global market. A proven European Market Access launch readiness and commmercialisation expert with 15 years in healthcare, health economics…